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Background: The mechanistic target of rapamycin complex1 (mTORC1) signaling pathway has been implicated in
functions of multicellular processes, including cell growth and metabolism. Although recent reports showed that
many signaling pathways, including Activin, Bmp, Fgf, sonic hedgehog, Insulin-like growth factor (IGF), Notch,
retinoic acid, and Wnt, are implicated in non-mammalian vertebrate regeneration, also known as epimorphic
regeneration, mTORC1 function remains unknown.
Results: To investigate the role of mTORC1 signaling pathway in zebrafish caudal fin, we examined the activation
and function of mTORC1 signaling using an antibody against phosphorylated S6 kinase and a specific inhibitor,
rapamycin. mTORC1 signaling is activated in proliferative cells of intra-ray and wound epidermal cells before blastema
formation, as well as in proliferative blastema cells, wound epidermal cells, and osteoblasts during regenerative
outgrowth. Before blastema formation, proliferation of intra-ray and wound epidermal cells is suppressed, but cell death
is not affected by mTORC1 signaling inhibition with rapamycin. Moreover, rapamycin treatment inhibits blastema and
wound epidermal cell proliferation and survival during blastema formation and regenerative outgrowth, as well as
osteoblast proliferation and differentiation during regenerative outgrowth. We further determined that mTORC1
signaling is regulated through IGF-1 receptor/phosphatidylinositol-3 kinase and Wnt pathways during fin regeneration.
Conclusion: Taken together, our findings reveal that mTORC1 signaling regulates proliferation, survival, and
differentiation of intra-ray cells, wound epidermis, blastema cells, and/or osteoblasts in various fin regeneration stages
downstream of IGF and Wnt signaling pathways.
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DifferentiationBackground
Mammalians present a limited ability for organ regener-
ation, whereas various non-mammalian vertebrates such
as teleosts and urodele amphibians show outstanding re-
generation ability. Among them, the zebrafish is a useful
animal model, which has been used to study the rege-
neration of several organs or appendages [1,2]. The adult
zebrafish caudal fin is composed of multiple cell types,
including fibroblast-like mesenchymal cells, osteoblasts,* Correspondence: yutaka@hiroshima-u.ac.jp
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regeneration process presents three stages: pre-blastema
formation, blastema formation, and regenerative out-
growth [3-5]. Following fin amputation, epidermal cells
migrate to cover the wound within 12 hours post amputa-
tion (hpa) [5]. The intra-ray mesenchymal cells and osteo-
blasts then migrate toward the amputation plane by 24
hpa (pre-blastema formation stage) [5]. From 18 to 24
hpa, these intra-ray mesenchymal cells and osteoblasts
begin to proliferate [3] and, as a result, a population of
these cells, named blastema, is formed underneath the
wound epidermis by 48 hpa (blastema formation stage).Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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blastema mainly consists of three distinct domains: the
distal blastema, proliferative zone, and differentiation zone
(72 hpa) [5,6]. The distal blastema barely contains prolifer-
ative blastema cells, and the proliferative zone contains
highly proliferative mesenchymal cells (the proximal med-
ial blastema) and osteoblasts (72 hpa) [3,5,6].
Since rapamycin presents various physiological functions
such as antifungal, immunosuppressive, and antiprolifera-
tive properties, many researchers have focused on the iden-
tification of rapamycin intracellular targets [7]. Mechanistic
target of rapamycin (mTOR), a serine/threonine kinase, has
been shown to be a rapamycin target in yeast, and most eu-
karyotes have this protein [7,8]. The mTOR signaling path-
way is mainly involved in cell growth and metabolism as
two distinct complex types, mTOR complex 1 (mTORC1)
and 2 (mTORC2) [7,8]. The mTORC1 signaling pathway is
involved in multicellular processes, including protein syn-
thesis, lipid synthesis, glycolysis, and autophagy, and is spe-
cifically inhibited by rapamycin [7,8]. mTORC1 signaling is
known to regulate protein synthesis mainly through direct
phosphorylation of S6 kinase (S6K) [7,8].
Many signaling pathways, including Activin, Bmp, Fgf,
sonic hedgehog, Insulin-like growth factor (IGF), Notch,
retinoic acid, Wnt, and reactive oxygen species (ROS), are
implicated in the regulation of cell proliferation and/or dif-
ferentiation in non-mammalian vertebrate regeneration,
also known as epimorphic regeneration [2,9-12]. However,
the spatiotemporal activation and function of the mTORC1
signaling pathway during epimorphic regeneration remains
unknown. In this study, we explored the activation and
function of mTORC1 signaling during various stages of
zebrafish caudal fin regeneration, and identified the up-
stream signaling pathway leading to mTORC1 signaling ac-
tivation during caudal fin regeneration.
Results
Spatiotemporal dynamism of mTORC1 signaling
activation during fin regeneration
To investigate the molecular mechanisms of regeneration,
we analyzed the signaling pathways involved in zebrafish
fin regeneration using various inhibitors and drugs. Our
experiments indicated that rapamycin, a well-known in-
hibitor of mTORC1 signaling, presented a strong inhibi-
tory effect on fin regeneration. To analyze the activation
of mTORC1 signaling during fin regeneration, spatiotem-
poral distribution of phosphorylated S6 kinase (p-S6K), an
activated form of S6K, was first examined by immunohis-
tochemistry. Although no p-S6K-positive cells were found
in intra-ray and epidermal cells immediately after fin am-
putation (0 hpa) (Figure 1A), p-S6K signals were detected
as early as 6 hpa (Figure 1B). The number of p-S6K-
positive cells in the intra-ray, epidermis, and blastema was
markedly increased, and p-S6K-positive cell localizationgradually changed with the progression of fin regener-
ation. These p-S6K-positive cells were widely distributed
in the intra-ray and wound epidermis proximal to the
amputation plane from 6 to 18 hpa (arrowheads in
Figure 1B-D). From 24 hpa, these cells started to accumu-
late underneath the wound epidermis, and p-S6K-positive
blastema cells were evident at 36 hpa (arrowheads in
Figure 1E,F). After 48 hpa, p-S6K-positive cells were
mainly detected in the blastema and wound epidermis. At
72 and 120 hpa, p-S6K signals were restricted to three dis-
tinct domains in the blastema, the putative proximal med-
ial blastema domain (arrowheads in Figure 1H,I’) [3], the
bilateral stripped-domains (arrows in Figure 1H,I’), where
differentiating osteoblasts and their progenitor cells are lo-
calized [11,13], and the wound epidermis. On the other
hand, it is interesting to note that p-S6K signals were ab-
sent in the tip of the putative proximal medial blastema do-
main and putative distal blastema (brackets in Figure 1G,
H,I’). These results suggest that, although the mTORC1
signaling pathway is widely activated in the intra-ray,
wound epidermal cells, and blastema cells until 48 hpa,
mTORC1 signaling is gradually restricted to the putative
proliferative blastema cells and osteoblasts after 72 hpa.
To characterize p-S6K-positive cells during the pre-
blastema formation (24 hpa) and regenerative outgrowth
stages (72 hpa), the fin regenerates were co-immunostained
with proliferating cell nuclear antigen (PCNA), a marker
for proliferative cells [14]; Zns-5, a marker for all osteo-
blasts independent of differentiation stages [15]; or Runx2,
an osteoblast progenitor marker [16]. At 24 hpa, almost
all p-S6K-positive intra-ray and blastema cells were
PCNA-positive (Figure 2A-C’), and all Runx2-positive
osteoblast progenitors were p-S6K-positive (Figure 2D-F’),
suggesting that mTORC1 signaling is active in prolifera-
tive cells and osteoblast progenitors during the pre-
blastema formation stage. At 72 hpa, PCNA-positive cells
in the putative proximal medial blastema domain were
p-S6K-positive (arrowheads in Figure 2I’), except that the
tip of the putative proximal medial blastema domain
(a bracket in Figure 2I’) was p-S6K-negative. In the
bilateral-stripped domains, Zns-5- or Runx2-positive cells
were p-S6K-positive (arrowheads in Figure 2L’,O’), except
in the most distal regions of these domains (brackets in
Figure 2L’,O’). A recent report showed that Runx2-positive
self-renewing preosteoblasts are localized in the most dis-
tal region and that Runx2/Sp7 (Osterix) double-positive
cells are differentiating osteoblasts [11]. Our results
suggest that mTORC1 signaling is active in proliferative
blastema cells and differentiating osteoblasts during
the regenerative outgrowth stage. These spatiotemporal
mTORC1 activation patterns prompted us to further
analyze the function of mTORC1 signaling in the pre-
blastema formation, blastema formation, and regenerative
outgrowth stages.
Figure 1 Spatiotemporal activation of S6K during zebrafish fin regeneration. (A-I’) Longitudinal sections of wild-type fin regenerates that
were immunohistochemically stained with an antibody against p-S6K (green) at 0 (A), 6 (B), 12 (C), 18 (D), 24 (E), 36 (F), 48 (G), 72 (H), and 120
(I,I’) hpa (0 hpa, n = 3; 6 hpa, n = 4; 12 hpa, n = 3; 18 hpa, n = 4; 24 hpa, n = 5; 36 hpa, n = 4; 48 hpa, n = 3; 72 hpa, n = 4; 120 hpa, n = 3). The
boxed area in I is enlarged in I’. DAPI fluorescent signal (blue) indicates the presence of nuclei. Dashed white lines indicate the amputation plane.
The p-S6K fluorescent signals were barely detectable in the amputated fin at 0 hpa (A). At 6 hpa, p-S6K-positive cells were found in both intra-ray
and epidermal cells (arrowheads in B), and the number of p-S6k-positive cells increased by 24 hpa (arrowheads in C, D, and E). Although p-S6K-
positive cells were found in both the blastema and intra-ray region adjacent to and proximal to the amputation plane at 36 hpa (arrowheads in
F), p-S6K-positive cells were mainly detected in the blastema at 48 hpa (arrowheads in G). At 72 and 120 hpa, p-S6K-positive cells were observed
in the bilateral strip regions (arrows in H and I’), in the putative proximal medial blastema (arrowheads in H and I’), and in the wound epidermis,
but not in the putative differentiated blastema cells (asterisks in H and I). Brackets indicate the p-S6K-negative cells in the tip of the putative
proximal medial blastema domain and putative distal blastema (G,H,I’). It should be noted that both p-S6K and DAPI fluorescent signals did not
overlap, as p-S6K and genomic DNA (DAPI specifically stains double-strand DNA) are localized in the cytosol and nucleus, respectively. Scale
bars: 100 μm.
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Figure 2 Distributions of S6K-positive cells and proliferative cells at 24 and 72 hpa. (A-F’) Longitudinal sections of wild-type fin regenerates
that were co-immunohistochemically stained with antibodies against p-S6K (green) and PCNA (red) (A-C’, n = 3) or p-S6K (green) and Runx2 (red)
(D-F’, n = 3) at 24 hpa. p-S6K positive cells were PCNA- or Runx2-positive at 24 hpa (C’,F’). The boxed areas in C and F are enlarged in C’ and F’,
respectively. Dashed white lines indicate the amputation planes. (G-O’) Longitudinal sections of wild-type fin regenerates that were co-
immunostained with antibodies against p-S6K (green) and PCNA (red) (G-I’, n = 5), p-S6K (green) and Zns-5 (red) (J-L’, n = 3), or p-S6K (green) and
Runx2 (red) (M-O’, n = 4) at 72 hpa. PCNA-positive cells were p-S6K-positive in the putative proximal medial blastema domain (arrowheads in I’),
but not in the tip of the putative proximal medial blastema domain (a bracket in I’). Zns-5- or Runx2-positive cells in the proximal lateral blastema
were also p-S6K-positive (arrowheads in L’ and O’), but cells in the distal region of the lateral blastema were not (brackets in L’ and O’). It should
be noted that both p-S6K and PCNA or Runx2 fluorescent signals did not overlap, because p-S6K and PCNA or Runx2 are localized in the cytosol
and nucleus, respectively. Scale bars: 100 μm. (P) Cartoon summarizing the anatomical structures of fin regenerates in longitudinal cross-sections
and localization of p-S6K-positive cells in the fin regenerates at 24 and 72 hpa. Dashed lines indicate the amputation planes.
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for cell survival during the pre-blastema formation stage
To examine the function of mTORC1 signaling during fin
regeneration, adult zebrafish were treated with a specific
mTORC1 inhibitor, rapamycin, 12 h before amputation
(-12 h) to 72 hpa (Figure 3A). Rapamycin significantly
inhibited fin regeneration compared to DMSO (Figure 3B,
C). In addition to rapamycin, we examined the two differ-
ent pharmacological inhibitors, Torin1 [17] and AZD8055
[18], in mTOR signaling inhibition, and found that fin re-
generation was also significantly inhibited by both Torin1
and AZD8055 treatment (Additional file 1: Figure S1).
mTORC1 signaling inhibition, by rapamycin, Torin1, and
AZD8055 was confirmed by the loss of p-S6K signal at 72
hpa (Additional file 2: Figure S2). The p-S6K signals were
markedly reduced by 3 h treatment with these inhibi-
tors (rapamycin, Torin1, and AZD8055) and were nearlyFigure 3 Rapamycin treatment inhibits fin regeneration until 72 hpa.
Rapamycin treatment significantly inhibited fin regeneration from – 12 h to
regenerative outgrowth stages), when compared to DMSO treatment. Dash
Error bars represent the standard error of 4 independent experiments. Scaldiminished by 6 h treatment (Additional file 3: Figure S3),
suggesting the specificity of p-S6K as readout of mTORC1
signaling. Furthermore, fin regeneration was also inhibited
by the knockdown of raptor, which encodes a component
of mTORC1 [7,8,19] using a morpholino antisense oligo
nucleotide (MO) (Additional file 4: Figure S4). Taken to-
gether, inhibition of mTORC1 signaling with these three
inhibitors (rapamycin, Torin1, and AZD8055) or by knock-
down of raptor suggests that mTORC1 signaling is re-
quired in the pre-blastema formation, blastema formation,
and regenerative outgrowth stages during fin regeneration.
We showed that mTORC1 signaling is active in prolif-
erative intra-ray cells and osteoblast progenitors during
the pre-blastema formation stage (Figure 2A-F’). To test
whether mTORC1 signaling affects cell proliferation be-
fore blastema formation, PCNA and Runx2 immunohis-
tochemical staining, a BrdU incorporation assay, and(A) Scheme of rapamycin treatment from – 12 h to 72 hpa. (B, C)
72 hpa (pre-blastema formation, blastema formation, and
ed lines indicate the amputation planes. ** p < 0.01 by Student’s t-test.
e bars: 500 μm in B.
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transgene using the transgenic fish XIG8A [Tg(ef1-α;
EGFP)] [21] were performed in rapamycin-treated fins.
Because cell proliferation starts at approximately 18 hpa in
regenerating fins [3], inhibition experiments of mTORC1
signaling by rapamycin treatment were performed from
-12 h to 18 hpa (or 24 hpa). mTORC1 signaling inhibition
was confirmed by the loss of the p-S6K signal at 24 hpa
(Additional file 5: Figure S5). At 18 hpa, the number of
PCNA-positive cells and the percent of Runx2-positive
cells were significantly reduced by rapamycin treatment
(Figure 4B-E), whereas the number of apoptotic cells
was not increased in the intra-ray and epidermal cells
(Figure 4F,G), indicating that inhibition of mTORC1 signal-
ing suppresses cell proliferation without inducing apoptosis.
Consistent with PCNA and Runx2 immunohistochemical
staining, the number of BrdU incorporated cells in both the
intra-ray and epidermis was significantly reduced by the
rapamycin treatment at 24 hpa (Figure 4H,I). It was previ-
ously reported that msxb and Xenopus ef1-α:EGFP trans-
gene are molecular markers for mesenchymal progenitor
cells [20] and proliferative cells [22] in the regenerating fins,
respectively. Similarly to PCNA and Runx2 expression,
msxb and Xenopus ef1-α:EGFP transgene expression was
markedly decreased by rapamycin treatment at 24 hpa as
determined by whole-mount in situ hybridization and
EGFP fluorescence, respectively (Figure 4J,K). These results
clearly indicate that mTORC1 signaling is required for cell
proliferation, but not in cell survival of intra-ray and epider-
mal cells before blastema formation.
mTORC1 signaling is required for cell proliferation and
cell survival during the regenerative outgrowth stage
Because p-S6K-positive cells start to accumulate under-
neath the wound epidermis from 24 hpa (Figure 1E),
and cell proliferation is suppressed until 24 hpa by
mTORC1 signaling inhibition (Figure 4), identifying the
function of mTORC1 signaling during blastema forma-
tion and regenerative outgrowth is difficult. We next ex-
amined the function of mTORC1 signaling during the
blastema formation and regenerative outgrowth stages
using rapamycin from 24 to 72 hpa (Figure 5A). Regen-
erative outgrowth was significantly inhibited by rapamy-
cin treatment from 24 to 72 hpa (Figure 5B,C), as
observed by rapamycin treatment from -12 h to 72 hpa
(Figure 3). mTORC1 signaling inhibition was confirmed
by the loss of the p-S6K signal at 72 hpa (Additional
file 6: Figure S6). In addition, msxb and connexin43 (cx43),
a molecular marker of proliferating cells [23], expression
was downregulated by rapamycin treatment in the regen-
erative fins (Figure 5D). Consistent with these in situ
hybridization results, the number of PCNA-positive cells
in both the blastema and epidermis was significantly re-
duced by rapamycin treatment (Figure 5E,F), as observedbefore blastema formation (Figure 4). In contrast to the
pre-blastema formation stage, the number of apoptotic
cells in both the blastema and epidermis was significantly
increased by rapamycin treatment during the blastema
formation and regenerative outgrowth stages (Figure 5G,
H). These results suggest that mTORC1 signaling is re-
quired for cell proliferation and cell survival during blas-
tema formation and regenerative outgrowth.
mTORC1 signaling is required for the proliferation and
differentiation of bony fin ray after 72 hpa
As shown in Figure 2, mTORC1 signaling was specifically
activated in the putative differentiating osteoblasts after 72
hpa. To examine the function of mTORC1 signaling in
bony ray formation, the regenerates were treated with
rapamycin from 72 to 120 hpa. Inhibition of mTORC1 sig-
naling was confirmed by the marked reduction of the p-
S6K signal at 120 hpa (Additional file 7: Figure S7). The
number of BrdU incorporated cells in the Zns-5-positive
osteoblasts was significantly reduced by rapamycin treat-
ment (Figure 6B,C). In addition, the number of Sp7-
expressing cells and expression domains of col10a1a,
which are intermediate markers of skeletogenesis [15],
were markedly decreased in the rapamycin-treated fins
(Figure 6D,E,F). In contrast to differentiation markers for
skeletogenesis, the number of Runx2-positive osteoblast
progenitors was unchanged by rapamycin treatment
(Figure 6G,H). These results suggest that mTORC1 sig-
naling is required for proliferation and differentiation of
the bony fin ray after 72 hpa.
mTORC1 signaling does not regulate autophagy in fin
regeneration
A recent study revealed that autophagy is required for zeb-
rafish fin regeneration under the control of MAPK/Erk
signaling pathway [24]. Because the mTORC1 signaling
pathway is known to inhibit autophagy [7,8], we examined
whether autophagy was affected by inhibition of mTORC1
signaling during fin regeneration. As determined using a
GFP-microtubule-associated protein 1 light chain 3 isoform
(GFP-LC3) transgenic line, autophagy was markedly upreg-
ulated from 1 to 4 days post amputation (dpa) [24]. Using
an LC3B antibody, we detected LC3 in the wound epider-
mis at 24 hpa, and by 72 hpa, LC3 localization in the wound
epidermis was maintained (Additional file 8: Figure S8).
Moreover, LC3 protein level and localization were not af-
fected by rapamycin treatment (Additional file 8: Figure S8),
suggesting that the mTORC1 signaling pathway does not
regulate fin regeneration via autophagy.
IGF-1 receptor (IGF-1R)/PI3K and Wnt signaling pathways
regulate mTORC1/S6K in fin regeneration
It is well known that the mTORC1/S6K pathway is re-
gulated through the receptor tyrosine kinase/PI3K/Akt
Figure 4 (See legend on next page.)
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Figure 4 Rapamycin treatment inhibits proliferation of intra-ray and epidermal cells, but not apoptosis before blastema formation.
(A) Scheme of rapamycin treatment before blastema formation. (B, C) PCNA-stained fin sections and quantification of PCNA-positive cells in the
intra-ray and epidermis at 18 hpa. The number of PCNA-positive cells was significantly reduced by rapamycin treatment in both the intra-ray and
epidermis at 18 hpa. **p < 0.01 by Student’s t-test. Error bars represent the standard error of 5 independent experiments. Scale bars: 100 μm. (D,E)
Runx2-stained fin sections and quantification of Runx2-positive cells in the intra-ray. Rapamycin treatment significantly reduced the percentage of
Runx2-positive cells at 18 hpa. *p < 0.05 by Student’s t-test. Error bars represent the standard error of 3 independent experiments. Scale bars: 100 μm.
(F, G) TUNEL-stained fin sections and quantification of TUNEL-positive intra-ray and epidermal cells. Cell death was not increased in both the intra-ray
and epidermis at 18 hpa. Error bars represent the standard error of 6 independent experiments. Scale bars: 100 μm. (H, I) BrdU-stained fin sections and
quantification of BrdU-positive cells in the intra-ray and epidermis. Rapamycin treatment significantly reduced the number of BrdU-positive cells in the
intra-ray and epidermis at 24 hpa. *p < 0.05 , **p < 0.01 by Student’s t-test. Error bars represent the standard error of 3 independent experiments. Scale
bars: 100 μm. DAPI fluorescent signal (blue) indicates the presence of nuclei (B, D, F, H). Dashed white lines indicate the amputation planes (B, D, F, H).
(J) Expression of msxb was examined by in situ hybridization at 24 hpa (n = 3). The msxb expression was barely detectable in rapamycin-treated fin
regenerates. Scale bars: 200 μm. (K) EGFP fluorescence of Tg(ef1-α;EGFP) fin regenerates at 24 hpa (n = 3). The EGFP fluorescence was lost in rapamycin-
treated fin regenerates. Scale bars: 200 μm. Dashed lines indicate the amputation plane (J, K).
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examine the upstream signaling pathway regulating
mTORC1/S6K signaling in fin regeneration, various inhib-
itors for IGF, Wnt, Fgf, and ROS signaling pathways were
tested from -12 h to 24 hpa or from 24 to 48 hpa, and
S6K activation was determined; IGF signaling (LY294002
[25]: a PI3K inhibitor, NVP-ADW742 [26]: a IGF-1 recep-
tor kinase inhibitor), Wnt signaling (IWP-2 [27]: a Wnt/β-
catenin signaling inhibitor), Fgf signaling (SU5402 [28]: a
Fgf receptor1 inhibitor), MAPK/Erk signaling (U0126 [29]:
a MAPK/Erk inhibitor), and ROS signaling (VAS2870
[30]: an inhibitor of NADPH oxidase). No inhibitory effect
for S6K activation was observed using SU5402, U0126, or
VAS2870, even though fin regeneration was suppressed
(Additional file 9: Figure S9). However, LY294002, NVP-
ADW742, and IWP-2 inhibitor treatment markedly re-
duced the p-S6K signal in blastema and epidermal cells.
The inhibitory effect of LY294002, NVP-ADW742, and
IWP-2 on S6K activation was nearly similar to that of
rapamycin during fin regeneration (Figure 7). These re-
sults suggest that both IGF-1R/PI3K and Wnt pathways
activate mTORC1 in blastema and epidermal cells during
zebrafish caudal fin regeneration.
Discussion
Based on the localization of p-S6K, we show the spatio-
temporal distributions of cells in which mTORC1 signal-
ing is activated during fin regeneration (Figure 1). Weak
p-S6K fluorescent signals were observed in the intra-ray
cells and epidermis as early as 6 hpa. Further, the p-S6K-
positive cells were found to be distributed in locations
proximal to the amputation plane by 36 hpa, indicating
that mTORC1 is one of the earliest signaling in fin regen-
eration, which is reminiscent of other signaling pathways
such as Wnt, Fgf, retinoic acid, and Activin [2,9,10]. We
also show that mTORC1 signaling is active in proliferative
blastema cells, wound epidermal cells, and osteoblasts
during blastema formation and regenerative outgrowth
(after 24 hpa) (Figure 2). Inhibition of mTORC1 signalingfrom 24 to 72 hpa suppresses proliferation of these
cells through the inhibition of S6K activation (Figure 5,
Additional file 6: Figure S6). These results suggest that
mTORC1 signaling is continuously required for cellular
proliferation during the blastema formation and regenera-
tive outgrowth stages via protein synthesis.
It is well established that mTORC1 signaling activates
anabolic processes, including the synthesis of proteins,
nucleotides, and lipids, and, as a result, these processes
promote cell growth and proliferation [7,8,31]. Protein
and nucleotide syntheses are controlled through the acti-
vation of S6K, and lipid synthesis is promoted by activat-
ing sterol regulatory element binding proteins in an
S6K-dependent or -independent manner [8,31]. Based
on these findings, the p-S6K-positive cells observed in
regenerating fins appear to be in a higher metabolic state
that is stimulated by a wound signal. It would be signifi-
cant to isolate and analyze these cells under high meta-
bolic conditions during fin regeneration.
A recent paper demonstrated that zebrafish caudal fin re-
generation is slightly inhibited by rapamycin treatment from
0 to 35 dpa [32]. However, the inhibitory effect of rapamy-
cin observed was milder than the effect observed in our
study. The rapamycin concentration used in this report was
lower than that used in the present study (50 nM in a previ-
ous report versus 2.4 μM in the present study), which may
explain this discrepancy. In addition, while fish were pre-
treated with rapamycin before amputation (-12 h) in our ex-
periments, no pretreatment was performed in the previous
report. In fact, we found that at least 6 h of pretreatment is
needed to observe the loss of p-S6K immunostaining. When
fish were treated with rapamycin from 0 hpa, the inhibitory
effect of rapamycin on fin regeneration was markedly re-
duced, even when using a 2.4 μM concentration of rapamy-
cin (data not shown). It is likely that these two different
experimental conditions may be responsible for the differ-
ence observed between our study and the previous report.
A previous report showed that insulin-like growth factor
2b (igf2b), which is expressed in blastema, activates the IGF
Figure 5 Rapamycin treatment inhibits both the proliferation and survival of intra-ray cells during the blastema formation and regenerative
outgrowth stages. (A) Scheme of rapamycin treatment during blastema formation and regenerative outgrowth stages. (B, C) Rapamycin treatment
significantly blocked the outgrowth of fin regenerates at 72 hpa. *p < 0.05 by Student’s t-test. Error bars represent the standard error of 4 independent
experiments. Scale bars: 500 μm. Dashed lines indicate the amputation plane. (D) Expression of msxb and cx43 was examined by whole-mount in situ
hybridization at 72 hpa (msxb, n = 5; cx43, n = 3). Rapamycin treatment induced the down-regulation of msxb and cx43 expression. Scale bars: 200 μm.
Dashed lines indicate the amputation plane. (E, F) PCNA-stained fin sections and quantification of PCNA-positive cells in the intra-ray and epidermis at
72 hpa. The number of PCNA-positive cells was significantly reduced by rapamycin treatment in both the blastema and epidermis at 72 hpa. **p < 0.01
by Student’s t-test. Error bars represent the standard error of 4 independent experiments. Scale bars: 100 μm. (G, H) TUNEL-stained fin sections and
quantification of TUNEL-positive cells in the intra-ray and epidermis. Cell death was significantly increased by rapamycin treatment in both the blastema
and epidermis at 72 hpa. **p < 0.01 by Student’s t-test. Error bars represent the standard error of 4 independent experiments. Scale bars: 100 μm. DAPI
fluorescent signal (blue) indicates the presence of nuclei (E, G).
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Figure 6 Rapamycin treatment inhibits proliferation and differentiation of osteoblasts after 72 hpa. (A) Scheme of rapamycin treatment
between 72 and 120 hpa. (B, C) BrdU and Zns-5 double-stained fin sections and quantification of BrdU and Zns-5 double-positive osteoblasts.
The number of double-positive osteoblasts was significantly reduced by rapamycin treatment at 120 hpa. **p < 0.01 by Student’s t-test. Error bars
represent the standard error of 4 independent experiments. (D, E) Sp7-stained fin sections and quantification of Sp7-positive osteoblasts. The
number of Sp7-positive osteoblasts was significantly reduced by rapamycin treatment at 120 hpa. DAPI fluorescent signal (blue) indicates the
presence of nuclei. **p < 0.01 by Student’s t-test. Error bars represent the standard error of 4 independent experiments. Scale bars: 100 μm.
(F) Expression of col10a1a was examined by in situ hybridization at 120 hpa (n = 4). Rapamycin treatment decreased col10a1a expression (brackets
in F) at 120 hpa. Dashed lines indicate the amputation planes. Scale bars: 200 μm. (G, H) Runx2-stained fin sections and quantification of
Runx2-positive cells. The number of Runx2-positive cells was not affected by rapamycin treatment at 120 hpa. Error bars represent the standard
error of 4 independent experiments. Scale bars: 100 μm.
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Figure 7 IGF-1R/PI3K and Wnt pathways regulate the activation of mTORC1 during fin regeneration. (A) Scheme of inhibitor treatments
of rapamycin, LY294002 (a PI3K inhibitor), NVP-ADW742 (an IGF-1R inhibitor), or IWP-2 (a Wnt/β-catenin inhibitor) during fin regeneration. (B-K)
Longitudinal sections of DMSO or inhibitors treated wild-type fin regenerates that were immunohistochemically stained with an antibody against
p-S6K (green) at 24 (DMSO, n = 6; Rapa, n = 4; LY294002, n = 4; NVP-ADW742, n = 4; IWP-2, n = 5) and 48 hpa (DMSO, n = 6; Rapa, n = 4; LY294002,
n = 4; NVP-ADW742, n = 4; IWP-2, n = 4). DAPI fluorescent signal (blue) indicates the presence of nuclei. The activation of S6K was blocked by
LY294002, NVP-ADW742, or IWP-2 treatment. Dashed white lines indicate the amputation planes. Scale bars: 100 μm.
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http://www.biomedcentral.com/1471-213X/14/42signaling pathway in the apical epithelium cells through two
receptors, insulin-like growth factor 1a receptor (Igf1ra) and
Igf1rb [33]. Pharmacological inhibition using NVP-
ADW541 or NVP-ADW742 caused apoptosis in the wound
epidermis and blocked blastema formation, indicating that
IGF signaling between blastema and wound epidermis is
critical for cell survival in the wound epidermis and cell
proliferation in the blastema [33]. These results are consist-
ent with some of our results showing that mTORC1signaling is active in the wound epidermis before blastema
formation, and is regulated by the IGF-1R/PI3K signaling
pathway. However, two phenotypic differences were ob-
served between mTORC1 and IGF-1R inhibition during fin
regeneration. One is that cell death was significantly in-
creased in the wound epidermis by IGF-1R inhibition at 24
hpa [33], but not by rapamycin treatment from -12 h to 18
hpa (Figure 4). Because the IGF signaling is one of upstream
signaling leading to mTORC1/S6K pathway, the other
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http://www.biomedcentral.com/1471-213X/14/42signaling pathways might be involved in the wound epider-
mis survival. The second is that activation of mTORC1
based on p-S6K localization was observed not only in the
wound epidermis, but also in intra-ray cells as early as 6
hpa. It is possible that, in intra-ray cells, mTORC1 signaling
is activated through IGF-1Rs, other than Igf1ra and Igf1rb.
In addition to IGF-1R/PI3K signaling, we also found that
Wnt signaling controls mTORC1 activation in both blas-
tema and epidermal cells during fin regeneration by using
IWP-2 (Figure 7). It has already been shown that Wnt sig-
naling directly activates mTORC1 through the inhibition of
glycogen synthase kinase 3 and tuberous sclerosis 1/2 in
zebrafish and mice [34], as well as in mammalian cell lines
[35]. In zebrafish caudal fin regeneration, Wnt/β-catenin sig-
naling indirectly regulates the proliferation of blastema cells,
patterning of epidermis, and differentiation and patterning
of bone, mediated through many signaling pathways such as
Activin, Notch, Fgf, retinoic acid, Hedgehog, IGF, and Bmp
[10]. Because mTORC1 signaling could be mediated directly
or indirectly through IGF signaling regulated by Wnt/β-
catenin signaling, further detailed investigations are needed
to elucidate the hierarchical relationship and crosstalk be-
tween IGF-1R/PI3K/mTORC1 and other signaling pathways
downstream of Wnt/β-catenin during fin regeneration.
Conclusions
In this study, we showed that the mTORC1 signaling is
activated in intra-ray and wound epidermal cells as early
as 6 hpa, and continues to be activated in proliferative
blastema cells, wound epidermal cells, and osteoblasts
during fin regeneration. Inhibition of mTORC1 signaling
during the pre-blastema formation, blastema formation,
and regenerative outgrowth stages by rapamycin suggests
that mTORC1 signaling is required for fin regeneration.
Before blastema formation, mTORC1 signaling is required
for intra-ray and wound epidermal cell proliferation, but
not in cell survival, whereas during the blastema forma-
tion and regenerative outgrowth stages, mTORC1 signal-
ing is required for both blastema and wound epidermal
cell proliferation and survival. Furthermore, during the re-
generative outgrowth stage, mTORC1 signaling is required
for both proliferation and differentiation of the bony fin
ray. In summary, our study is the first report that uncovers
the requirement and significance of mTORC1 signaling
for the cell proliferation, cell survival, or differentiation of
intra-ray cells, blastema cells, wound epidermal cells, and/
or osteoblasts during vertebrate epimorphic regeneration
downstream of IGF and Wnt signaling pathways.
Methods
Zebrafish husbandry, fin amputation, drug treatments,
and in vivo electroporation
All zebrafish experiments were performed under ethical
approval of the Hiroshima University Animal ResearchCommittee (Permit Number: F13-1). Maintenance and
caudal fin amputation of adult zebrafish (AB/Tüebingen
strain) were performed as described previously [36].
Transgenic zebrafish XIG8A [Tg(ef1-α:EGFP)] [21] was
used for fin amputation experiments.
During drug treatments, fish were kept in fish water at
28.5°C and the fish water with drug was replaced daily.
2.4 μM rapamycin (LC Laboratories), 100 nM Torin1
(Calbiochem), 1.2 μM AZD8055 (AdooQ Biosciences),
10 μM LY294002 (Calbiochem), 5 μM NVP-ADW742
(AdooQ Biosciences), 14 μM SU5402 (Calbiochem),
10 μM IWP-2 (Promega), 25 μM U0126 (Promega), and
1 μM VAS2870 (Enzo Life Sciences) were used as spe-
cific inhibitors. All were dissolved in DMSO and final
DMSO concentration in fish water was 0.1%, except
SU5402 (0.17%). The control fish were kept in fish water
with 0.1% DMSO.
For MO knockdown experiments, in vivo electropor-
ation was performed as described previously [37]. The
MO was micro-injected between each bony fin ray and
electroporated before fin amputation. We used fluorescent
tagged-MO targeted against raptor and 5-base mismatch
control MO (Gene Tools, Inc.) as following; a raptor MO
(5′-ATGGATGGATGGATGCTCACCTATC-3′) [19], a
5-mismatch control MO (5′- ATGaATGaATGaATGaT-
CACaTATC -3′, lower case letters indicate mismatch
pairs).
Immunohistochemical staining and whole-mount in situ
hybridization
The amputated fins were fixed in 4% paraformaldehyde in
0.1 M phosphate-buffered saline (PBS) overnight at 4°C.
After fixation, the fins were treated with PBS containing
30% sucrose overnight, and were embedded with Tissue-
Tek O.C.T. compound (Sakura Finetek). The embedded
fins were frozen and sectioned to 14 μm thickness by using
a Leica CM3050S. The sections were dehydrated and rehy-
drated through a methanol/PBS-0.1% Tween series for
5 min each. After rehydration, the sections were blocked
with PBST (PBS and 0.1% Tween20) containing 5% sheep
serum for 3 h at room temperature and then incubated in
PBST with primary antibody/antibodies overnight at 4°C.
The following primary antibodies were used: anti-PCNA
mouse monoclonal antibody at 1:1000 (Sigma, #P8825)
[36]; anti-BrdU rat monoclonal antibody at 1:100 (Abcam,
ab6326); phospho-S6 ribosomal protein (Ser240/244)
rabbit polyclonal antibody at 1:300 (Cell Signaling, #2215)
[38]; anti-Runx2 mouse monoclonal antibody at 1:100
(Sant Cruz Biotechnology, 27-K) [10,11]; anti-Zns-5
mouse monoclonal antibody at 1:300 (a kindly gift from
Dr. Ishitani) [14]; anti-Sp7 rabbit polyclonal antibody at
1:1000 (Santa cruz, sc-22536-R) [11]; anti-LC3B rabbit
polyclonal antibody at 1:300 (Abcam, ab51520) [39]. The
following secondary antibodies were used: Alexa Fluor®
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Technologies Corp.); Alexa Fluor® 488 goat anti-rat IgG
antibody at 1:500 (Invitrogen, Life Technologies Corp.);
Alexa Fluor® 594 goat anti-mouse IgG antibody at 1:500
(Invitrogen, Life Technologies Corp.); Alexa Fluor® 594 goat
anti-rabbit IgG Antibody at 1:500 (Invitrogen, Life Tech-
nologies Corp.). 4′,6-diamidino-2-phenylindole (DAPI) was
used for nuclei staining at a concentration of 1:1000. The
images were captured using an Olympus FV1000-D con-
focal microscope with the same exposure times using the
FluoView software.
Whole-mount in situ hybridization analyses were per-
formed as described previously [40] with 60 minute pro-
teinase K treatment.
BrdU incorporation assays and cell death detection
BrdU incorporation assays were performed as described
previously [36]. Fin-amputated fish were allowed to regen-
erate in the fish water containing with 50 μg/ml BrdU be-
tween 18 to 24 hpa or 108 to 120 hpa. After incubation,
the regenerating fins were cut and BrdU-labeled cells were
detected as described previously [36]. For detection of
apoptotic cells, we performed TUNEL staining using an In
Situ Cell Death Detection Kit (Roche Applied Science) ac-
cording to the manufacture’s instruction.
Additional files
Additional file 1: Figure S1. Treatment of Torin1 or AZD8055 inhibits
fin regeneration until 72 hpa. (A) Scheme of Torin1 or AZD8055
treatment from – 12 h to 72 hpa. (B,C) Treatment of both inhibitors
significantly inhibited fin regeneration from – 12 h to 72 hpa
(pre-blastema formation, blastema formation, and regenerative
outgrowth stages), when compared to DMSO treatment. Dashed lines
indicate the amputation planes. *p < 0.05 , **p < 0.01 by Student’s t-test.
Error bars represent the standard error of 4 independent experiments.
Scale bars: 500 μm in B.
Additional file 2: Figure S2. Distributions of p-S6K in rapamycin, Torin1,
or AZD8055-treated fin regenerates at 72 hpa. (A) Scheme of rapamycin,
Torin1, or AZD8055 treatment from – 12 h to 72 hpa. (B) Longitudinal
sections of wild-type fin regenerates that were immunohistochemically
stained with an antibody against p-S6K (green) at 72 hpa (DMSO, n = 5;
Rapa, n = 3; Torin1, n = 3; AZD8055, n = 3). DAPI fluorescent signal (blue)
indicates the presence of nuclei. At 72 hpa, the p-S6K fluorescent signal was
lost in rapamycin, Torin1, or AZD8055-treated fin regenerates. Dashed white
lines indicate the amputation plane. Scale bars: 100 μm.
Additional file 3: Figure S3. p-S6K signals were markedly reduced by 3
or 6 h treatment with inhibitors (rapamycin, Torin1, and AZD8055). (A)
Scheme of rapamycin, Torin1, or AZD8055 treatment from 24 h to 27 or 30
hpa. (B-I) Longitudinal sections of wild-type fin regenerates that were
immunohistochemically stained with an antibody against p-S6K (green) at
27 hpa (DMSO, n = 3; Rapa, n = 3; Torin1, n = 3; AZD8055, n = 3) or 30 hpa
(DMSO, n = 3; Rapa, n = 3; Torin1, n = 3; AZD8055, n = 3). DAPI fluorescent
signal (blue) indicates the presence of nuclei. The p-S6K signals were
markedly reduced by 3 or 6 h treatment with inhibitors (rapamycin, Torin1,
and AZD8055). Dashed white lines indicate the amputation plane. Scale bars:
100 μm.
Additional file 4: Figure S4. Fin regeneration and activation of
mTORC1 signaling are inhibited by raptor knock-down. (A,B) Wild-type fin
electroporated in the ventral half with fluorescein-labeled MOs at 72 hpa.Fin regeneration was significantly inhibited by raptor knock-down.
Dashed lines indicate the amputation planes. Scale bars: 500 μm.
**p < 0.01 by Student’s t-test. Error bars represent the standard error of 5
independent experiments. (C) Longitudinal sections of wild-type fin
regenerates that were immunostained with antibodies against p-S6K
(red) at 24 hpa (5-mismached raptor MO, n = 5; raptor MO, n = 5). Green
fluorescence indicates the presence of MO in the electroporated cells.
Merged views showed that cells incorporated 5-mismached raptor MO,
but not raptor MO, are p-S6K-positive (arrowheads). It should be noted
that fluorescent signals of 5-mismached raptor MO and p-S6K overlap
only in the cytosol, because p-S6K are localized in the cytosol, not in the
nucleus. Dashed white lines indicate the amputation planes. Scale bars:
100 μm.
Additional file 5: Figure S5. Distributions of p-S6K in rapamycin-treated
fin regenerates at 24 hpa. (A) Scheme of rapamycin treatment from – 12 h
to 24 hpa. (B) Longitudinal sections of wild-type fin regenerates that were
immunohistochemically stained with an antibody against p-S6K (green) at
24 hpa (DMSO, n = 4; Rapa, n = 4). DAPI fluorescent signal (blue) indicates
the presence of nuclei. At 24 hpa, the p-S6K fluorescent signal was lost in
rapamycin-treated fin regenerates. Dashed white lines indicate the
amputation plane. Scale bars: 100 μm.
Additional file 6: Figure S6. Distributions of p-S6K in fin regenerates
treated with rapamycin from 24 to 72 hpa. (A) Scheme of rapamycin
treatment from 24 to 72 hpa. (B) Longitudinal sections of wild-type fin
regenerates that were immunohistochemically stained with an antibody
against p-S6K (green) at 72 hpa (DMSO, n = 5; Rapa, n = 5). DAPI
fluorescent signal (blue) indicates the presence of nuclei. At 72 hpa, the
p-S6K fluorescent signal was lost in rapamycin-treated fin regenerates.
Dashed white lines indicate the amputation plane. Scale bars: 100 μm.
Additional file 7: Figure S7. Distributions of p-S6K in fin regenerates
treated with rapamycin from 72 to 120 hpa. (A) Scheme of rapamycin
treatment from 72 to 120 hpa. (B) Longitudinal sections of wild-type fin
regenerates that were immunohistochemically stained with an antibody
against p-S6K (green) at 120 hpa (DMSO, n = 3; Rapa, n = 3). DAPI fluorescent
signal (blue) indicates the presence of nuclei. At 120 hpa, the fluorescent
signal of p-S6K was markedly reduced by rapamycin treatment. Scale bars:
100 μm.
Additional file 8: Figure S8. Distributions of LC3B in rapamycin treated
fin regenerates. (A) Scheme of rapamycin treatment from -12 to 24 hpa
or from 36 to 72 hpa. (B,C) Longitudinal sections of DMSO or rapamycin
treated wild-type fin regenerates that were immunohistochemically
stained with an antibody against LC3B (green) at 24 hpa (DMSO,
n = 4; Rapa, n = 4) and 72 hpa (DMSO, n = 3; Rapa, n = 3). DAPI fluorescent
signal (blue) indicates the presence of nuclei. LC3B is specifically localized
in the wound epidermis at 24 and 72 hpa. Dashed white lines indicate
the amputation planes. Scale bars: 100 μm.
Additional file 9: Figure S9. Fgf, MAPK/Erk, and ROS signaling pathways
do not regulate the activation of mTORC1 during fin regeneration.
(A) Scheme of inhibitor treatments of SU5402 (a Fgf receptor1 inhibitor),
U0126 (a MAPK/Erk inhibitor), and VAS2870 (an NADPH oxidase inhibitor:
ROS signaling) during fin regeneration. (B-I) Longitudinal sections of DMSO or
inhibitors treated wild-type fin regenerates that were immunohistochemically
stained with an antibody against p-S6K (green) at 24 or 48 hpa. DAPI
fluorescent signal (blue) indicates the presence of nuclei. The p-S6K signals in
SU5402-, U0126-, and VAS2870-treated fins were approximately comparable
to those in DMSO-treated fins at both 24 hpa (DMSO, n = 6; SU5402, n = 5;
U0126, n = 3; VAS2870, n = 3) and 48 hpa (DMSO, n = 6; SU5402, n = 4;
U0126, n = 3; VAS2870, n = 3), even though these inhibitors, at 48 hpa,
prevented fin regeneration. Dashed white lines indicate the amputation
planes. Scale bars: 100 μm.
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